These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 32776551)

  • 1. Association between markers of immune response at hospital admission and COVID-19 disease severity and mortality: A meta-analysis and meta-regression.
    Khinda J; Janjua NZ; Cheng S; van den Heuvel ER; Bhatti P; Darvishian M
    J Med Virol; 2021 Feb; 93(2):1078-1098. PubMed ID: 32776551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    Moutchia J; Pokharel P; Kerri A; McGaw K; Uchai S; Nji M; Goodman M
    PLoS One; 2020; 15(10):e0239802. PubMed ID: 33002041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
    Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.
    Zhao Y; Yin L; Patel J; Tang L; Huang Y
    J Med Virol; 2021 Jul; 93(7):4358-4369. PubMed ID: 33739452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and coagulation dysfunction in adults: A systematic review and meta-analysis.
    Lin J; Yan H; Chen H; He C; Lin C; He H; Zhang S; Shi S; Lin K
    J Med Virol; 2021 Feb; 93(2):934-944. PubMed ID: 32706426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis.
    Melo AKG; Milby KM; Caparroz ALMA; Pinto ACPN; Santos RRP; Rocha AP; Ferreira GA; Souza VA; Valadares LDA; Vieira RMRA; Pileggi GS; Trevisani VFM
    PLoS One; 2021; 16(6):e0253894. PubMed ID: 34185801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRP, SAA, LDH, and DD predict poor prognosis of coronavirus disease (COVID-19): a meta-analysis from 7739 patients.
    Wang L; Yang LM; Pei SF; Chong YZ; Guo Y; Gao XL; Tang QY; Li Y; Feng FM
    Scand J Clin Lab Invest; 2021 Dec; 81(8):679-686. PubMed ID: 34762008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients.
    Benotmane I; Perrin P; Vargas GG; Bassand X; Keller N; Lavaux T; Ohana M; Bedo D; Baldacini C; Sagnard M; Bozman DF; Chiesa MD; Cognard N; Olagne J; Delagreverie H; Marx D; Heibel F; Braun L; Moulin B; Fafi-Kremer S; Caillard S
    Transplantation; 2021 Jan; 105(1):158-169. PubMed ID: 33009284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis.
    Gungor B; Atici A; Baycan OF; Alici G; Ozturk F; Tugrul S; Asoglu R; Cevik E; Sahin I; Barman HA
    Am J Emerg Med; 2021 Jan; 39():173-179. PubMed ID: 33069541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.
    Singh K; Mittal S; Gollapudi S; Butzmann A; Kumar J; Ohgami RS
    Int J Lab Hematol; 2021 Apr; 43(2):324-328. PubMed ID: 33010111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboinflammatory Biomarkers in COVID-19: Systematic Review and Meta-analysis of 17,052 Patients.
    Chaudhary R; Garg J; Houghton DE; Murad MH; Kondur A; Chaudhary R; Wysokinski WE; McBane RD
    Mayo Clin Proc Innov Qual Outcomes; 2021 Apr; 5(2):388-402. PubMed ID: 33585800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample.
    Hasan I; Rashid T; Suliman S; Amer H; Chirila RM; Mai ML; Jarmi T; Khouzam S; Franco PM; Heilig CW; Wadei HM
    Rom J Intern Med; 2021 Mar; 59(1):10-42. PubMed ID: 33155999
    [No Abstract]   [Full Text] [Related]  

  • 17. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.
    Velavan TP; Kuk S; Linh LTK; Lamsfus Calle C; Lalremruata A; Pallerla SR; Kreidenweiss A; Held J; Esen M; Gabor J; Neurohr EM; Shamsrizi P; Fathi A; Biecker E; Berg CP; Ramharter M; Addo MM; Kreuels B; Kremsner PG
    Sci Rep; 2021 Jul; 11(1):14471. PubMed ID: 34262116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
    Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
    Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis.
    Ghayda RA; Lee J; Lee JY; Kim DK; Lee KH; Hong SH; Han YJ; Kim JS; Yang JW; Kronbichler A; Smith L; Koyanagi A; Jacob L; Shin JI
    Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32668763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.
    Bonetti G; Manelli F; Patroni A; Bettinardi A; Borrelli G; Fiordalisi G; Marino A; Menolfi A; Saggini S; Volpi R; Anesi A; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1100-1105. PubMed ID: 32573995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.